Bromide

Bromide

SCHEMBL1204327

Br.O=C(CBr)c1cnc2cnccn12

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
PRMT5 O14744 1/20 0.32
WDR77 Q9BQA1 1/20 0.32
GPR139 Q6DWJ6 1/20 0.32
SLC27A1 Q6PCB7 1/20 0.32
ABL1 P00519 1/20 0.31
KIT P10721 1/20 0.31
BCR P11274 1/20 0.31
DDR1 Q08345 1/20 0.31
PKM P14618 1/20 0.31
HDAC1 Q13547 1/20 0.30
EPHB3 P54753 1/20 0.30
RIPK2 O43353 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14053633 0.98 NPC1 (0.33) NPC1RAB9APRMT5WDR77GPR139
SCHEMBL20226852 0.83 DDR1 (0.36) NPC1RAB9APRMT5WDR77GPR139
SCHEMBL2868846 0.78 KDM4E (0.38) NPC1RAB9APRMT5WDR77ABL1
SCHEMBL1203406 0.77 NPC1 (0.35) NPC1RAB9APRMT5WDR77GPR139
SCHEMBL16324761 0.77 TGFBR1 (0.41)
SCHEMBL16392314 0.77 NPC1 (0.38) NPC1RAB9APRMT5WDR77ABL1
SCHEMBL6112768 0.76 NPC1 (0.55) NPC1RAB9ASLC27A1KITDDR1
SCHEMBL20226862 0.73 ABL1 (0.34) NPC1RAB9APRMT5WDR77GPR139
SCHEMBL20223635 0.73 GPR139 (0.34) NPC1RAB9APRMT5WDR77GPR139
SCHEMBL17837095 0.73 TGFBR1 (0.42) NPC1RAB9AABL1KITBCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893280-B2 2,4-disubstituted thiazolyl derivatives JANSSEN PHARMACEUTICA NV (BE) 2011-02-22 US disclosed
EP-1261607-B1 2,4-DISUBSTITUTED THIAZOLYL DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2008-11-12 EP disclosed
US-20060211704-A1 2,4-Disubstituted thiazolyl derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2006-09-21 US disclosed
US-7105550-B2 2,4-disubstituted thiazolyl derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2006-09-12 US disclosed
US-20030203897-A1 2,4-Disubstituted thiazolyl derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2003-10-30 US disclosed
EP-1261607-A1 2,4-DISUBSTITUTED THIAZOLYL DERIVATIVES Janssen Pharmaceutica N.V. (BE) 2002-12-04 EP disclosed
WO-2001064674-A1 2,4-DISUBSTITUTED THIAZOLYL DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 2001-09-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211704-A1 2,4-Disubstituted thiazolyl derivatives IL4, PTGER4, PTGER3 NPC1 1418/4885RAB9A 3507/4885PRMT5 1521/4885
US-20030203897-A1 2,4-Disubstituted thiazolyl derivatives IL4, PTGER4, PTGER1 NPC1 799/4885RAB9A 3677/4885PRMT5 1159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.